1 |
continuous subcutaneous insulin infusion
(1382 times)
|
Endocrinology (807 times)
|
MDI (336 times) CGM (146 times) T1D (122 times)
|
1979 Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.
|
2 |
continuous s.c. insulin infusion
(29 times)
|
Endocrinology (20 times)
|
MDI (6 times) T1D (4 times) BG (3 times)
|
1983 The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
|
3 |
coherent speech intelligibility index
(4 times)
|
Audiology (3 times)
|
NCM (2 times) CSE (1 time) ESTOI (1 time)
|
2012 Contributions of cochlea-scaled entropy and consonant-vowel boundaries to prediction of speech intelligibility in noise.
|
4 |
continuous subcutaneous infusion of insulin
(4 times)
|
Medicine (2 times)
|
AD-SoS (1 time) BTT (1 time) CSC (1 time)
|
1983 The improved response in endogenous insulin due to continuous subcutaneous infusion of insulin therapy in juvenile diabetes.
|
5 |
comprehensive stage II
(2 times)
|
Cardiology (2 times)
|
PCA (1 time)
|
2021 Incidence of and Risk Factors for Aortic Arch Interventions After the Comprehensive Stage II Procedure for Hypoplastic Left Heart Syndrome.
|
6 |
continuous insulin infusion using the subcutaneous
(2 times)
|
Endocrinology (2 times)
|
IDD (1 time)
|
1983 Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
|
7 |
Cumulative Somatosensory Impairment Index
(2 times)
|
Physical Medicine (1 time)
|
SEPs (1 time)
|
2011 Sensorimotor and psychosocial correlates of adaptive locomotor performance in older adults.
|
8 |
BACKGROUND: Subcutaneous insulin infusion
(1 time)
|
Endocrinology (1 time)
|
---
|
2017 Type 1 Diabetes and Long-Term Continuous Subcutaneous Insulin Infusion Therapy: A 10-Year Experience from Macedonia.
|
9 |
calsarcin II
(1 time)
|
Cell Biology (1 time)
|
CSI (1 time) HS (1 time)
|
2015 Reduced expression of MyHC slow isoform in rat soleus during unloading is accompanied by alterations of endogenous inhibitors of calcineurin/NFAT signaling pathway.
|
10 |
can be achieved with insulin pump therapy
(1 time)
|
Endocrinology (1 time)
|
DKA (1 time)
|
1999 Insulin pump therapy in type 1 pediatric patients: now and into the year 2000.
|
11 |
Cardiff Self-Injury Inventory
(1 time)
|
Medicine (1 time)
|
DSHI (1 time) SBQ-R (1 time)
|
2023 The Cardiff Self-Injury Inventory (English version): Convergent validity and psychometric properties.
|
12 |
case on the basis of the emminens eConecta reports
(1 time)
|
Endocrinology (1 time)
|
MDI (1 time)
|
2017 Evaluation of a New Digital Automated Glycemic Pattern Detection Tool.
|
13 |
casiopeina II-gly
(1 time)
|
Pharmacology (1 time)
|
CSIII (1 time)
|
2005 Cardiotoxicity of copper-based antineoplastic drugs casiopeinas is related to inhibition of energy metabolism.
|
14 |
changed from intensive therapy with pen to insulin pump-treatment
(1 time)
|
Nursing (1 time)
|
---
|
1997 Effect of patient-selected intensive insulin therapy on quality of life.
|
15 |
characterize the long-term effect of insulin pump therapy
(1 time)
|
Ophthalmology (1 time)
|
ERG (1 time) HbA1c (1 time)
|
2015 Baseline haemoglobin A1c influences retinal function after long-term insulin pump therapy.
|
16 |
children treated with insulin pumps
(1 time)
|
Endocrinology (1 time)
|
CI (1 time) T1D (1 time)
|
2019 Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register ENDA.
|
17 |
Clinical stage II
(1 time)
|
Neoplasms (1 time)
|
CT (1 time) RLND (1 time) RT (1 time)
|
2018 Clinical Stage IIA-IIC Seminoma: Radiation Therapy versus Systemic Chemotherapy versus Retroperitoneal Lymph Node Dissection.
|
18 |
come first: an insulin pump
(1 time)
|
Endocrinology (1 time)
|
CGM (1 time) T1D (1 time)
|
2019 Advanced Technology in the Management of Diabetes: Which Comes First-Continuous Glucose Monitor or Insulin Pump?
|
19 |
CONCLUSION: The percentage of children on pumps
(1 time)
|
Endocrinology (1 time)
|
HbA1c (1 time) SE (1 time) SMBG (1 time)
|
2014 Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
|
20 |
consumer susceptibility to interpersonal influence
(1 time)
|
Health Services (1 time)
|
---
|
2004 Smoking among university students in Canada and South Korea: linking diffusion theory with consumer susceptibility to interpersonal influence.
|
21 |
continuous infusion of insulin
(1 time)
|
Endocrinology (1 time)
|
---
|
2005 Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus.
|
22 |
continuous insulin infusion pump therapy
(1 time)
|
Endocrinology (1 time)
|
MDI (1 time) T1DM (1 time)
|
2012 Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitus.
|
23 |
continuous subcutaneous infusions of rapid-acting insulin analogues
(1 time)
|
Endocrinology (1 time)
|
glargine-MDI (1 time)
|
2011 Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
|
24 |
Continuous subcutaneous insulin infusion in children
(1 time)
|
Pediatrics (1 time)
|
---
|
1983 [Continuous subcutaneous insulin infusion in children (CSII)].
|
25 |
continuous subcutaneous insulin infusion using a portable battery-powered infusion pump
(1 time)
|
Endocrinology (1 time)
|
---
|
1980 Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps.
|
26 |
continuous subcutaneous insulin infusion utilizing an external insulin infusion pump
(1 time)
|
History of Medicine (1 time)
|
NPH (1 time)
|
2005 [New methods in insulin treatment].
|
27 |
continuous, long-term, dual-rate subcutaneous insulin infusion
(1 time)
|
Medicine (1 time)
|
---
|
1979 Long-term continuous subcutaneous insulin infusion in diabetics at home.
|
28 |
conventional insulin pump based diabetes care
(1 time)
|
Medical Informatics (1 time)
|
INCA (1 time)
|
2007 HIS modelling and simulation based cost-benefit analysis of a telemedical system for closed-loop diabetes therapy.
|
29 |
CRC-specific inflammatory index
(1 time)
|
Inflammation (1 time)
|
CRC (1 time) SII (1 time)
|
2020 Creation of a Novel Inflammation-Based Score for Operable Colorectal Cancer Patients.
|
30 |
Cross-sector Innovation Initiative
(1 time)
|
Health Services (1 time)
|
---
|
2022 Evaluation of the First Year of the Cross-Sector Innovation Initiative: Lessons Learned in Advancing Cross-Sector Alignment.
|
31 |
CSII group
(1 time)
|
Endocrinology (1 time)
|
MDI (2 times) T1DM (1 time)
|
2010 Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
|
32 |
CSII than during ICT
(1 time)
|
Endocrinology (1 time)
|
ICT (1 time) IDDM (1 time)
|
1988 Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen.
|
33 |
CSII treated patients at first
(1 time)
|
Endocrinology (1 time)
|
MDI (1 time)
|
2013 Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
|
34 |
Cytisus scoparius seed lectin II
(1 time)
|
Biochemistry (1 time)
|
Con A (1 time) HPLC (1 time)
|
1992 The primary structure of the Cytisus scoparius seed lectin and a carbohydrate-binding peptide.
|